Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BradsaudeBSP:SAUD3 -1.42%91 3-Year EPS without NRI Growth Rate is 18.10% as of Jun. 2026, which is 51% above its 10-year median of 12.00. GuruFocus rates BSP:SAUD3 with a GF Score™ of 91/100 and a GF Value™ of R$23.31 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 17 Healthcare Plans companies, Bradsaude ranks better than 70.59% on this metric.
During the past 12 months, Bradsaude's average EPS without NRI Growth Rate was -7.30% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 18.10% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 10.10% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 8.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Bradsaude was 69.60% per year. The lowest was -9.00% per year. And the median was 12.00% per year.
Bradsaude (BSP:SAUD3) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Bradsaude 3-Year EPS without NRI Growth Rate Related Terms
BSP:SAUD3 vs UNH, CVS, ELV: 3-Year EPS without NRI Growth Rate Comparison
For the Healthcare Plans subindustry, Bradsaude's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bradsaude 3-Year EPS without NRI Growth Rate vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Bradsaude's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Bradsaude's 3-Year EPS without NRI Growth Rate falls into.
Bradsaude 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 18.10% mean?
Bradsaude (BSP:SAUD3) has a 3-Year EPS without NRI Growth Rate of 18.10% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Bradsaude and its competitors. This is 51% above median its historical median of 12.00. According to the industry distribution chart, Bradsaude ranks #5 out of 17 companies in the Healthcare Plans industry, placing it in the top 29.4%.
Is Bradsaude's 3-Year EPS without NRI Growth Rate too high?
Bradsaude's current 3-Year EPS without NRI Growth Rate of 18.10% is 51% above median its 10-year median of 12.00. The Healthcare Plans industry median 3-Year EPS without NRI Growth Rate is 1.40. Bradsaude's value of 18.10% is 1192.9% above this industry median. Based on the distribution chart, Bradsaude ranks #5 out of 17 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Bradsaude has a GF Score™ of 91/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bradsaude's 3-Year EPS without NRI Growth Rate compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Bradsaude ranks #5 out of 17 companies for 3-Year EPS without NRI Growth Rate. This puts Bradsaude in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 1.40. Bradsaude's value of 18.10% is 1192.9% above this benchmark. While the company's 10-year median is 12.00 vs. the industry median of 1.40, Bradsaude has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Plans company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Plans companies is 1.40, based on 17 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bradsaude's current 3-Year EPS without NRI Growth Rate of 18.10% is 1192.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Bradsaude and its competitors. For the Healthcare Plans industry, the median 3-Year EPS without NRI Growth Rate is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bradsaude's current 3-Year EPS without NRI Growth Rate is 18.10%, which is 51% above median its own 10-year median of 12.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bradsaude stock overvalued right now?
Based on GuruFocus' analysis, Bradsaude (BSP:SAUD3) is currently considered Possible Value Trap. The stock's GF Value™ is R$23.31, compared to a current price of R$14.53 — trading 37.7% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 18.10%, which is 51% above median its 10-year median of 12.00 and 1192.9% above the Healthcare Plans industry median of 1.40. Bradsaude's overall GF Score™ is 91/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Bradsaude (BSP:SAUD3), the current 3-Year EPS without NRI Growth Rate is 18.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bradsaude (BSP:SAUD3) Overvalued in 2026?
Based on GuruFocus' analysis, Bradsaude stock appears to be undervalued.
The current stock price of R$14.53 is trading 37.7% below its estimated GF Value™ of R$23.31.
GuruFocus considers Bradsaude to be Possible Value Trap.
Key valuation signals for BSP:SAUD3:
3-Year EPS without NRI Growth Rate: 18.10% (51% above median its 10-year median of 12.00)
GF Value™: R$23.31 vs. price of R$14.53 (37.7% below fair value)
Industry Position: 1192.9% above the Healthcare Plans median (#5 of 17)
No single metric tells the full story. See the BSP:SAUD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bradsaude SA operates a healthcare ecosystem in Brazil formed through the consolidation of companies across different healthcare segments. Its operations include health and dental insurance, hospitals, primary care clinics, healthcare technology, diagnostics, and oncology services. The company serves more than 13 million beneficiaries and operates a healthcare network that includes approximately 4,000 hospital beds across the country.
91GF Score
Get the complete analysis for BSP:SAUD3
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:SAUD3 has been successfully added to your 
